This week on BackTable Urology, Dr. Seth Lerner (Baylor College of Medicine) discusses the intricacies of lymph node dissection in bladder cancer management, including an overview of patterns of metastasis, genomic classifiers, and recent clinical trials.
The discussion highlights the evolution of bladder cancer treatment, from the use of cytotoxic chemotherapy to the current practice of neoadjuvant chemotherapy and radical cystectomy. Dr. Lerner and Dr. Bagrodia further explore diagnostic and treatment strategies, including the role of Decipher Prostate Genomic Classifier in tailoring patient treatment plans. The podcast delves into the necessity of a multidisciplinary approach to bladder cancer, the benefits of multimodal therapy, and the integration of circulating tumor DNA in management plans. Dr. Lerner then discusses clinical trials assessing the impact of extended lymph node dissection during cystectomies and emphasizes the importance of surgical quality and adherence to established protocols in bladder cancer treatment.
---
CHECK OUT OUR SPONSOR
Veracyte
[ Ссылка ]
---
SHOW NOTES
00:00 - Introduction
06:17 - The Role of Imaging in Bladder Cancer Staging
08:00 - Exploring the Potential of Genomic Classifiers
16:55 - Debating the Efficacy of Extended Lymph Node Dissection
27:47 - Update on Bladder Cancer Clinical Trials
48:54 - Final Thoughts and the Future of Bladder Cancer Treatment
---
The BackTable Urology Podcast is a resource for practicing urologists to learn tips, techniques, and practical advice from their peers in the field. Listen on BackTable.com/Urology or on the streaming platform of your choice.
Get notified when new episodes drop! Subscribe to the BackTable Urology Podcast on your go-to podcast platform, and follow us on your social media platform of choice for regular updates.
► [ Ссылка ]
#bladdercancer #lymphadenectomy#urologiconcology
